Drug Development Process (Drug Discovery) Equipment
-
Manufactured by Advanced Electrophoresis Solutions Ltd. (AES)based in CANADA
With our ISO:9001 certification, AES is proud to offer a comprehensive range of critical consumables, including proprietary cartridges, ampholytes, pI markers, electrolytes, and general solutions and consumables. In particular, we are pleased to supply high-quality 0.5% and 1% Methyl Cellulose (MC) solutions for icIEF analysis. Our MC solutions are fast, long-lasting, and compatible with ...
-
Manufactured by Suono Biobased in USA
We have reimagined ultrasound as a simple and effective delivery platform, which acts on the therapeutic molecules themselves, achieving ultra-rapid, formulation-independent drug delivery. This enables us to “push” virtually any therapeutic class, including temperamental molecules, like nucleic acids, directly into ...
-
Manufactured by Ncardia Services B.V.based in NETHERLANDS
The discovery that transformed biological research. In 2007, Shinya Yamanaka and Kazutoshi Takahashi were able to reprogram human somatic cells into pluripotent stem cells by inducing the expression of four embryonic transcription factors. The resultant cells were called human induced pluripotent stem cells (iPSC). iPSCs have unlimited proliferation capacity and can be differentiated into nearly ...
-
based in USA
Opal is the first end-to-end integrated drug discovery & development platform. Traditional, linear approaches to target discovery and drug development have created sub-optimized systems that are intrinsically disintegrated and ...
-
Manufactured by Vivesto ABbased in SWEDEN
Many intravenously delivered Active Pharmaceutical Ingredients (APIs) are insoluble or poorly soluble in water. This can be a major hurdle in pharmaceutical development and may cause promising drugs to fail during the development process and may limit the application of approved drugs because of poor solubility. ...
-
Manufactured by COGNISIONbased in USA
COGNISION® is cleared by the FDA. COGNISION® is an objective biomarker system that offers clarity in a field of complexity. By facilitating an objective evaluation of patients with cognitive disorders, COGNISION® helps neurologists and other physicians differentiate between dementia and depression, track disease progression and assess overall cognitive deficits associated with ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you